Is an electronic signature legally binding?

Yes. Under the federal ESIGN Act (15 U.S.C. §7001) and state UETA provisions, electronic signatures are enforceable when parties demonstrate intent, consent to do business electronically, attribution to a signer, and reliable record retention. Certain exceptions, like wills and some court filings, remain ineligible.

Do I need notarization or witnesses?

Generally no. Notarization and witness requirements are not typical for commercial contracts, but certain jurisdictions or specific instruments may require them. Remote online notarization is permitted in most states with varying rules; verify state notary statutes and RON requirements before relying on electronic acknowledgements.

Who must sign the agreement?

Authorized signers must have corporate authority to bind their organization—typically an officer, director, or delegated representative. For entities, confirm signatory name and title, and, where required, obtain a board resolution or power of attorney documenting signing authority to prevent later challenges.

How should I retain signed records?

Store executed agreements and audit trails in a secure, access-controlled system supporting PDF/A export and tamper-evident storage. Follow federal retention minima (IRS three years, HIPAA six years) and preserve metadata and audit logs to support regulatory audits and legal defensibility.

Can PHI be included and signed electronically?

Yes, if the eSignature workflow complies with HIPAA safeguards. Use a vendor that signs a Business Associate Agreement, enforces access controls, and preserves audit trails. Maintain consent and disclosures for patient data and follow 45 CFR §164.530(j) retention rules for PHI.

Are there tax or reporting obligations?

Potentially. Payments such as royalties or milestone fees may create withholding or information reporting obligations; ensure payers collect correct TINs and issue required forms. Consult IRC §6721 for information return penalties and confirm backup withholding rules where TINs are missing.

Electronic Signature
Templates
Miscellaneous
Pharmaceutical Agreement

Pharmaceutical Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Pharmaceutical Agreement

This Pharmaceutical Agreement ("Agreement") is entered into as of Effective Date: by and between:

Parties

Supplier / Party A — Company Name Supplier / Party A — Address Recipient / Party B — Company Name Recipient / Party B — Address

Recitals

WHEREAS, Supplier: engages in the research, development, manufacture and/or supply of pharmaceutical products and related materials; and

WHEREAS, Recipient: desires to engage Supplier to provide the services and/or products described herein under the terms and conditions set forth in this Agreement; and

WHEREAS, the parties intend that Supplier perform services and deliver product meeting the specifications, regulatory requirements, and quality standards set forth below.

Scope of Work

Supplier shall perform the services and/or supply pharmaceutical product as described in this Section. Supplier's obligations include development, manufacturing, quality control, release testing, labeling, packaging, and documentation necessary for regulatory compliance, as applicable.

Detailed Scope

Payment Terms

In consideration for the performance of the Scope of Work, Recipient shall pay Supplier the fees set forth below in accordance with the invoicing and payment schedule. All fees are exclusive of taxes unless otherwise stated.

Total Contract Amount Payment Schedule / Milestones Payment Method Late Payment Fee Invoice Recipient / Billing Address

Term and Termination

Term: This Agreement shall commence on Start Date: and shall continue until End Date: unless earlier terminated in accordance with this Section.

Notice Period for Termination (for convenience)

Termination for Cause: Either party may terminate this Agreement for material breach by the other party if such breach is not cured within thirty (30) days after written notice specifying the breach. Termination shall be without prejudice to any rights or remedies available at law or equity.

Effects of Termination: Upon expiration or termination, Supplier shall deliver completed work and all documentation to Recipient, Recipient shall pay for all work performed through the effective date of termination, and the parties shall comply with the survival provisions set forth in this Agreement.

Confidentiality

Each party (the "Receiving Party") shall hold in strict confidence and shall not disclose to any third party any confidential or proprietary information of the other party (the "Disclosing Party") disclosed in connection with this Agreement. Confidential information includes, without limitation, formulations, processes, manufacturing parameters, regulatory submissions, clinical data, pricing and commercial terms, and business plans.

Confidentiality Duration (years)

Exceptions: Confidential information does not include information that is (a) publicly known other than by breach of this Agreement, (b) rightfully received from a third party without restriction, (c) independently developed without use of the Disclosing Party's confidential information, or (d) required to be disclosed by law or regulation, provided the Receiving Party gives prompt written notice and cooperates with the Disclosing Party to seek protective measures.

Regulatory Compliance; Quality

Supplier warrants that all products and services provided under this Agreement shall comply with applicable laws, regulations, current Good Manufacturing Practices (cGMP), and all regulatory requirements in the jurisdictions where product is to be supplied. Supplier shall maintain records and provide access to documentation to permit Recipient to demonstrate regulatory compliance as reasonably requested.

Minimum Insurance Requirement

Indemnification

Each party agrees to indemnify, defend and hold harmless the other party from and against any and all claims, liabilities, damages, losses and expenses (including reasonable attorneys' fees) arising out of the indemnifying party's negligence, willful misconduct, or breach of representations, warranties or obligations under this Agreement, except to the extent caused by the negligence or willful misconduct of the other party.

Governing Law

This Agreement shall be governed by and construed in accordance with the laws of the jurisdiction specified below without regard to conflict of law principles.

Governing Law (State or Jurisdiction)

Entire Agreement; Amendment

This Agreement, together with any attachments, exhibits and mutually executed purchase orders or statements of work, constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior and contemporaneous agreements, proposals and communications, whether written or oral. No amendment shall be effective unless in writing and signed by authorized representatives of both parties.

Miscellaneous Provisions

Severability: If any provision of this Agreement is held invalid or unenforceable, the remainder shall continue in full force and effect. Waiver: Failure to enforce any provision shall not constitute a waiver of future enforcement. Notices: Notices shall be in writing and delivered to the addresses set forth above or such other address as may be designated in writing.

Execution

The parties have caused this Agreement to be executed by their duly authorized representatives as of the Effective Date first written above.

Supplier / Party A — Printed Name:

By:

Date:

Recipient / Party B — Printed Name:

By:

Date:

What a Pharmaceutical Agreement Covers

A Pharmaceutical Agreement is a legally binding contract that sets terms for the development, manufacture, distribution, licensing, or clinical testing of pharmaceutical products and related services. Typical provisions cover scope of work, regulatory responsibilities, data sharing, intellectual property rights, confidentiality, quality control, pricing, delivery, indemnification, and termination. For electronic execution, parties should confirm intent and consent and follow U.S. e-signature law (ESIGN Act, 15 U.S.C. §7001) and applicable state UETA provisions to ensure enforceability. Accurate party identification and retention of signed records supports later regulatory review.

Why a Clear Agreement Matters

A Pharmaceutical Agreement clarifies responsibilities, reduces regulatory risk, and preserves IP and data rights while defining commercial terms. Using a clear, compliant agreement helps streamline audits, supports FDA or partner due diligence, and preserves evidence of consent and performance obligations.

Who Typically Executes a Pharmaceutical Agreement

Typical signatories include pharmaceutical sponsors, contract manufacturing organizations, clinical research organizations, and licensing partners involved in product lifecycle activities.

Pharmaceutical sponsor: defines development milestones, funding, regulatory submissions, and related obligations.
Contract manufacturer: covers quality standards, lot release, and compliance with GMP obligations.
CRO or licensing partner: handles trials, data access, IP licensing, and commercialization terms.

Use the agreement template as a starting point and tailor clauses to the transaction, jurisdiction, and regulatory obligations.

Core Sections to Include in the Agreement

Core sections of a Pharmaceutical Agreement define responsibilities, performance metrics, regulatory duties, IP, commercial terms, and dispute resolution mechanisms tailored to drug and device projects.

Scope of Work

Defines services, deliverables, timelines, milestones, acceptance criteria, and change control procedures to align expectations across development, manufacturing, or clinical activities, including reporting and escalation requirements.

Regulatory Compliance

Assigns responsibility for regulatory filings, inspections, pharmacovigilance, safety reporting, and adherence to FDA, EMA, and other applicable authority requirements during the agreement term, including recordkeeping obligations.

Intellectual Property

Specifies ownership, licensing scope, background IP, foreground discoveries, patent prosecution, confidentiality, and rights to use data for regulatory or commercialization purposes, including sublicensing and post-termination exploitation rights.

Quality & Delivery

Includes GMP adherence, batch release criteria, inspection access, deviations handling, product recall procedures, and timelines for supply and change notifications with metrics, remedies, and audit rights.

Commercial Terms

Sets pricing, delivery schedules, payment terms, price adjustments, exclusivity, milestones, royalties, milestone payments, and conditions for rebates or refunds, including tax treatment, invoicing procedures, and dispute resolution for invoices.

Liability & Indemnity

Allocates risk, indemnification scope, caps on liability, consequential damage exclusions, insurance requirements, and procedures for claims and limitation periods, including defense control, notice obligations, and subrogation.

Step-by-Step: From Draft to Execution

Follow this stepwise process to prepare, negotiate, and execute a Pharmaceutical Agreement securely and in compliance with U.S. electronic signature laws.

01

Prepare Draft: Assemble scope, schedules, and regulatory exhibits.
02

Internal Review: Legal, regulatory, quality, and commercial must review.
03

Negotiate Terms: Track changes, confirm IP and liability provisions.
04

Execute: Collect signatures and retain an audit trail.

Configure an Electronic Workflow

Configure an electronic workflow to automate field population, routing, and signer authentication for Pharmaceutical Agreements.

Field	Configuration
Template Variables	Auto-fill party and product fields.
Routing Order	Define sequential or parallel signing.
Authentication	Use email, SMS, or KBA as needed.
Retention Settings	Enable PDF/A export and archive.

Where Signed Agreements Are Sent or Filed

Typical submission paths and destinations depend on counterparty, regulator, and contract obligations; choose secure delivery and record retention mechanisms.

To Partner: Send executed copy to counterparty legal and supply teams.
Regulatory Filing: Attach executed agreement in IND or submission package.
Internal Records: Store signed PDF in secure document management.
Contract Management: Register contract in CLM with renewal alerts.

Platform and Integration Considerations

Use platforms that support PDF, DOCX, audit trails, and required compliance frameworks such as ESIGN, UETA, and HIPAA when handling protected health information.

File Formats: PDF, DOCX, and XML supported.
Integrations: Salesforce, NetSuite, Google Workspace.
Security: TLS 1.2/1.3 and AES-256 at rest.

Essential Information to Include

Parties: Legal entity names and addresses

Effective Date: Contract start date in MM/DD/YYYY format

Product Details: Compound identifiers, formulation, and strength

Regulatory IDs: IND, NDA, ANDA numbers or application IDs

Payment Terms: Pricing, milestones, and invoicing schedule

Confidentiality: Scope of protected information and duration

Common Preparation Mistakes to Avoid

Using vague scope language that leads to disputes over deliverables, causing delays in manufacturing, regulatory filings, and missed milestone payments.
Failing to assign regulatory responsibilities clearly between sponsor and manufacturer, which can result in noncompliance during FDA inspections or adverse event reporting lapses.
Mismatched party names, missing signer authority, or incorrect dates that undermine enforceability and trigger disputes or payment withholding.
Neglecting data access and IP transfer mechanics, including scope of license and post-termination data rights, which creates commercialization obstacles.

Key Risks and Potential Consequences

Regulatory Fines: Potential FDA enforcement and fines.

Contract Breach: Liability for missed milestones.

Loss of IP: Inadequate assignment risks ownership disputes.

Payment Withholding: Counterparty may delay payments.

Recordkeeping Violation: Failure to retain audit trail harms defense.

Tax Consequences: Misstated royalties affect tax reporting.

Timelines, Deadlines, and Processing Expectations

Key timing obligations include performance milestones, regulatory filing windows, payment schedules, and record retention; specify deadlines clearly to avoid penalties or missed filings.

Execution Deadline:

Set effective date and signature deadline to trigger obligations.

Milestone Payments:

Tie payments to acceptance tests or regulatory approvals.

Regulatory Filings:

Allow time for agency review and supplemental submissions.

Invoice Due Dates:

Specify invoice terms and late fee calculations.

Renewal Notice:

Require notice 60–90 days before automatic renewal.

Practical Examples of Agreement Use

Real-world examples show how Pharmaceutical Agreements solve manufacturing, licensing, and clinical challenges across organizations of varying size and complexity.

Mid-Size Sponsor

A mid-size sponsor used a standardized Pharmaceutical Agreement to onboard a contract manufacturer for clinical supply, minimizing negotiation time and clarifying responsibilities.

Defined cGMP obligations and batch release process.
The clear allocation of regulatory duties and quality acceptance criteria prevented delays during inspection, reduced change-order disputes, and enabled timely supply of clinical material across multiple global sites under consistent commercial terms.

CRO Partnership

A CRO and sponsor negotiated a data-sharing and IP license annex to clarify ownership of trial data and post-trial publication rights before study start.

Specified data access and publication timelines.
Early agreement on data custody, anonymization, and publication reduced sponsor-CRO disputes, preserved patent filing timelines, and ensured that regulatory submissions included consistent datasets and properly attributed analyses.

eSignature Vendor Pricing and Feature Snapshot

Comparison of typical entry-level plans and select features across major eSignature vendors for Pharmaceutical Agreement workflows.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes (Premium)	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No cap	100 envelopes/user/year	Varies	Varies	Varies

Frequently Asked Questions

Frequently asked questions address execution, enforceability, signing authority, notarization, record retention, and eSignature compliance for Pharmaceutical Agreements.

Need help? Contact support

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now